View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Search Results for Bioniche Life Sciences Inc

Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20 Next >

Refine Search

Display Mode: Context | Summary

Bioniche Announces Resignation of its CFO

2009 AUG 17 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Bioniche Life Sciences Inc.

Price: $3.00

Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM)

2009 APR 13 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Bladder Cancer

Price: $3.00

Bioniche Invited to Participate in Canadian Beef Value Chain Roundtable

2009 FEB 16 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Immunization

Price: $3.00

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin

2009 JUL 20 ... Bioniche Life Sciences Inc. (TSX: BNC) and Endo Pharmaceuticals (NASDAQ: ENDP) jointly announced that Endo has ...

Subject: Endo Pharmaceuticals Inc.

Price: $3.00

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

2009 JUL 27 ... Bioniche Life Sciences Inc. (TSX: BNC) and Endo Pharmaceuticals (NASDAQ: ENDP) jointly announced that Endo has ...

Subject: Bladder Cancer

Price: $3.00

Bioniche Named One of the Top 50 Best Small and Medium Employers in Canada

2009 JAN 26 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, is ...

Subject: Bioniche Life Sciences Inc.

Price: $3.00

Bioniche Provides a Corporate Update

2009 MAY 11 ... Bioniche Life Sciences Inc. ("Bioniche"; TSX: BNC), a research-based, technology-driven Canadian ...

Subject: Bioniche Life Sciences Inc.

Price: $3.00

Bioniche Repays Revolving Credit Facility

2009 AUG 3 ... Bioniche Life Sciences Inc. ("Bioniche"; TSX: BNC), a research-based, technology-driven Canadian ...

Subject: Pharmaceuticals

Price: $3.00

Bioniche Reports Fiscal 2009 Third Quarter

2009 MAY 18 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Bioniche Life Sciences Inc.

Price: $3.00

Bioniche Reports Fiscal 2009 Year-End Results

2009 OCT 5 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Cancer Vaccines

Price: $3.00

Bioniche Reports Fiscal 2010 First Quarter Results and Achievement of First Milestone Under Licensing Agreement

2009 NOV 16 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Cancer Vaccines

Price: $3.00

Bioniche Represented at House of Commons Sub-Committee on Food Safety

2009 JUN 8 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Food Poisoning

Price: $3.00

Bioniche Revolving Credit Facility Maturity Date Amended

2009 MAR 16 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Bioniche Life Sciences Inc.

Price: $3.00

Bioniche Warrants' Expiration Date to be Extended

2009 MAR 2 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Bioniche Life Sciences Inc.

Price: $3.00

Econiche(TM) Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease

2009 JUL 27 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Vaccine Efficacy

Price: $3.00

Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference

2008 JUL 7 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Immunization

Price: $3.00

Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary

2008 JUL 21 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Immunization

Price: $3.00

Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production

2008 JUL 7 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Food Poisoning

Price: $3.00

E. coli O157 Vaccine Efficacy Reinforced by Study Published in Foodborne Pathogens and Disease

2008 NOV 3 ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

Subject: Escherichia Coli

Price: $3.00

Results 1 - 20 Next >


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx